Search
for
Sort by
Research 211–240 of 1000+
- Hallmark evidence of lipopolysaccharide (LPS) tolerance in obese women with polycystic ovary syndrome (PCOS) - LPS-induced NFkB suppression in mononuclear cells (MNC) is linked to hyperandrogenism in PCOS
- HDL as Therapeutic Tools
- Treatment of Alopecia Areata With Tofacitinib
- Finasteride for the Treatment of Hidradenitis Suppurativa in Children and Adolescents
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Oral Minoxidil in the Treatment of Hypertensive Crisis
- Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Three orphans one should know: red scalp, red ear and red scrotum syndrome
- Tumor Necrosis Factor in Sepsis
- CUTANEOUS T-CELL LYMPHOMA
- Modulation of macrophage functions by ECM-inspired wound dressings – a promising therapeutic approach for chronic wounds
- Association of a polymorphism in the ornithine decarboxylase gene with male androgenetic alopecia
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Combining 308-monochromatic excimer phototherapy with monthly IM triamcinolone acetonide for the treatment of resistant alopecia totalis
- More than One Way to Skin a Wound
- Chemotherapy and Cutaneous Drug Reactions
- Therapeutic Efficacy and Safety of Platelet-Rich Plasma (PRP) for Hair Restoration: A Narrative Review
- (101) Ovarian Hyperthecosis as a Cause of Hypersexualization in a Post-menopausal Female
- The role of Extracellular Vesicles in Alopecia and its Treatment
- The Itchy Scalp
- Contents
- More Yellow Ovaries
- Reply
- Books Received
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Polycystic ovary syndrome and impact on health
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism